Evaluating the clinical effectiveness of new beta-lactam/beta-lactamase inhibitor combination antibiotics: A systematic literature review and meta-analysis

BACKGROUND: Ceftazidime/avibactam (C/A), ceftolozane/tazobactam (C/T), imipenem/relebactam (I/R), and meropenem/vaborbactam (M/V) combine either a cephalosporin (C/T and C/A) or a carbapenem antibiotic (M/V and I/R) with a β-lactamase inhibitor. They are used to treat carbapenem-resistant Enterobact...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Geneva M., Fitzpatrick, Margaret A., Walding, Kyle, Gonzalez, Beverly, Schweizer, Marin L., Suda, Katie J., Evans, Charlesnika T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495535/
https://www.ncbi.nlm.nih.gov/pubmed/36168482
http://dx.doi.org/10.1017/ash.2021.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495535/
https://www.ncbi.nlm.nih.gov/pubmed/36168482
http://dx.doi.org/10.1017/ash.2021.217

Ejemplares similares